DEBILINE DIN 00145491
Status: Cancelled Post Market
Holder: LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC.
Molecule: DEOXYCHOLIC ACID
Health Canada record
| Active ingredient(s) | DEOXYCHOLIC ACID 100 MG; PEPSIN 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | ETHICAL |
| Class | Human |
| ATC | A09AC01 PEPSIN AND ACID PREPARATIONS |
| Original market date | 31-Dec-1951 |
| Current status date | 28-Sep-1999 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DEOXYCHOLIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02443910 | BELKYRA | ABBVIE CORPORATION | Solution | DEOXYCHOLIC ACID 10 MG | Marketed |
| 00145653 | DEBILINE H | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | Tablet | DEOXYCHOLIC ACID 100 MG; HOMATROPINE METHYLBROMIDE 2.5 MG; PEPSIN 50 MG | Cancelled Post Market |
International API supply for DEOXYCHOLIC ACID
1 valid EDQM Certificates of Suitability from 1 holders. 9 active FDA Drug Master Files.
Request a quote for DEBILINE